Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Choosing the right guide to retirement planning is crucial for your future. Learn essential steps to secure a comfortable retirement.
22,974 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Electric vehicle leaders are increasingly defined by their software and AI capabilities. This guide highlights three ...
Bitcoin holds near $71,000 as geopolitical risk cools, yet a raft of macro factors and an ETF decision window keep th...
The Roundhill COSW ETF remains focused on generating weekly income by selling calls on COST, a structure that caps ga...
The Magnificent Seven have driven market gains, but AI spending is fueling new ideas. Could this stock better bargain...
PennantPark Investment’s hefty yield hinges on a reserve that funds part of its payouts and a portfolio heavy in floa...
Value stocks are regaining ground in May as investors rotate from growth; the VLUE, AVUV, and VBR trio are delivering...
European Union and United States trade talks accelerate, threatening tariff changes that could ripple through inflati...
As AI accelerates, Nvidia has driven eye-popping gains. But with new competitors and a crowded AI ecosystem, is Nvidi...
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
As housing demand cools, Home Depot and Lowe’s diverge on dividend resilience. Home Depot shows stronger cash flow an...
A single market signal suggests SpaceX's IPO could roar, but history warns investors not to blindly chase headlines. ...